Description

ANGIZEM CD 180MG

Indications

ANGIZEM CD 180MG is primarily indicated for the management of hypertension (high blood pressure) and the treatment of angina pectoris (chest pain). It is also utilized in the management of certain types of arrhythmias (irregular heartbeats). By effectively controlling blood pressure and alleviating angina symptoms, ANGIZEM CD contributes to improved cardiovascular health and reduced risk of heart-related complications.

Mechanism of Action

ANGIZEM CD contains Diltiazem, a calcium channel blocker that exerts its therapeutic effects by inhibiting the influx of calcium ions into cardiac and smooth muscle cells. By blocking the L-type calcium channels, Diltiazem reduces myocardial contractility, decreases heart rate, and dilates peripheral blood vessels. This action leads to a decrease in myocardial oxygen demand and an increase in oxygen supply, which is particularly beneficial in patients with angina. Furthermore, the vasodilatory effects of Diltiazem help lower systemic vascular resistance, contributing to its antihypertensive properties.

Pharmacological Properties

ANGIZEM CD is characterized by its extended-release formulation, allowing for once-daily dosing. This formulation provides a sustained therapeutic effect, maintaining stable plasma concentrations of Diltiazem throughout the day. The pharmacokinetics of Diltiazem indicate that it is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 4-6 hours after administration. The drug undergoes extensive hepatic metabolism, primarily via cytochrome P450 3A4, and is excreted in urine as metabolites. The half-life of Diltiazem is approximately 3-5 hours, although the extended-release formulation prolongs its effects.

Contraindications

ANGIZEM CD is contraindicated in patients with known hypersensitivity to Diltiazem or any of its components. It should not be used in individuals with severe hypotension (low blood pressure), advanced aortic stenosis, or in patients with a history of sick sinus syndrome or second- or third-degree atrioventricular block without a functioning pacemaker. Additionally, caution is advised in patients with severe hepatic or renal impairment, as these conditions may affect the metabolism and excretion of the drug.

Side Effects

Common side effects associated with ANGIZEM CD include dizziness, headache, fatigue, and peripheral edema (swelling of the legs or ankles). Gastrointestinal disturbances such as nausea, constipation, and abdominal discomfort may also occur. Less frequently, patients may experience bradycardia (slow heart rate), hypotension, or skin reactions such as rash or itching. Serious adverse effects, although rare, may include heart failure or liver dysfunction. Patients should be monitored for any unusual symptoms and report them to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of ANGIZEM CD for adults is typically 180 mg once daily, which may be adjusted based on the patient’s response and tolerance. The maximum recommended dose is 360 mg per day. It is important to take ANGIZEM CD at the same time each day to maintain consistent blood levels of the medication. The capsules should be swallowed whole and not crushed or chewed, as this may alter the extended-release properties of the formulation. Patients are advised to follow their healthcare provider’s instructions regarding dosage adjustments and to not discontinue the medication abruptly without consulting their provider.

Interactions

ANGIZEM CD may interact with several other medications, which can alter its effectiveness or increase the risk of side effects. Notably, concurrent use of other antihypertensive agents may lead to additive effects, resulting in hypotension. Caution is advised when using Diltiazem with medications that are metabolized by cytochrome P450 3A4, such as certain statins, benzodiazepines, and antiarrhythmics, as this may increase their plasma levels and the potential for toxicity. Patients should inform their healthcare provider of all medications, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before initiating treatment with ANGIZEM CD, a thorough medical history and assessment of the patient’s cardiovascular status is essential. Special caution should be exercised in elderly patients, those with a history of heart failure, or those with significant renal or hepatic impairment. Regular monitoring of blood pressure and heart rate is recommended to ensure the medication is effectively managing the patient’s condition without causing adverse effects. Patients should be advised to avoid alcohol consumption while taking ANGIZEM CD, as it may exacerbate side effects such as dizziness and hypotension.

Clinical Studies

Clinical studies have demonstrated the efficacy of Diltiazem in reducing blood pressure and alleviating angina symptoms. In randomized controlled trials, patients treated with ANGIZEM CD showed significant reductions in systolic and diastolic blood pressure compared to placebo. Additionally, studies have indicated that Diltiazem effectively improves exercise tolerance and reduces the frequency of angina attacks in patients with stable angina pectoris. Long-term studies have also suggested that Diltiazem may have favorable effects on cardiovascular outcomes, including a reduction in the incidence of myocardial infarction and hospitalization due to heart failure.

Conclusion

ANGIZEM CD 180MG is an effective medication for the management of hypertension and angina, offering the benefits of a once-daily dosing regimen due to its extended-release formulation. Understanding its mechanism of action, potential side effects, and drug interactions is crucial for optimizing treatment outcomes. Patients should be closely monitored throughout their treatment to ensure safety and efficacy, and any concerns should be promptly addressed by healthcare professionals.